Abstract In acute hypoxia, the release of nitric oxide (NO) produced in rat carotid body is unclear. The concentration of NO was measured electrochemically with a Pt/Nafion/Pd-IrOx/POAP-modified electrode placed on the surface of isolated carotid bodies superfused with bicarbonate-buffer saline at 35°C. In hypoxia, the concentration of NO in the carotid body was increased by 17±2 nM. The amount of NO release during hypoxia was augmented by increasing the number of carotid bodies surrounding the electrode and also in the presence of L-arginine. In addition, the hypoxia-induced elevation of NO was abolished by pretreatment with a nitric oxide synthase (NOS) inhibitor, L-N G -nitroarginine methylester (L-NAME). The results suggest that endogenous NO production in the carotid body increases during hypoxia. Electrophysiological measurement of single fiber activity in the sinus nerve revealed that L-NAME treatment enhances the afferent discharge in response to hypoxia. This confirms that the hypoxia-induced elevation of NO suppresses the carotid chemoreceptor response to hypoxia. Taken together, it is concluded that acute hypoxia increases NO generation in the rat carotid body, and that the elevated levels of NO suppress carotid chemoreceptor activity during hypoxia. Hence, NO may play an active inhibitory role in the control of carotid chemoreceptor activity during hypoxia.
Introduction
Chemoreceptors in the carotid body increase afferent nerve activity to regulate cardiorespiratory performance during hypoxia. The hypoxic response of the chemoreceptors is modulated by nitric oxide (NO), presumably produced by NO synthase (NOS) in nerve fibers and vascular endothelium in the carotid body (see [22] for review). It is well known that NO inhibits carotid chemoreceptor activity. Hence, numerous studies have shown that NO generated by exogenous sources such as NO donors reduces the carotid chemoreceptor's response to hypoxia [7, 14, 30] . Importantly, a competitive NOS inhibitor, L-N G -nitroarginine methylester (L-NAME), enhances the hypoxic response of the carotid body in situ [7, 27] and in vitro [30] , despite having minimal effects on the basal activity. This suggests that the endogenous production of NO increases during hypoxia. Yet, there is no direct evidence to support this hypothesis. On the other hand, Kramer [17] postulated that the augmentation of carotid chemosensory activity in acute hypoxia may be due to the decreased availability of an inhibitory chemical messenger. This idea is supported by observations that NOS is less active in low-O 2 medium than in the air control [23] . The decreased NOS activity may attenuate endogenous NO production during hypoxia in the carotid body and this may lead to "disinhibition" of carotid chemoreceptor activity.
At present, there is little information on the direct measurement of NO levels in the carotid body. In addition, the effect of acute hypoxia on the change, if any, of endogenous production of NO in the carotid body is uncertain. Recently, Buerk and Lahiri [6] measured tissue NO levels in isolated and perfused cat carotid body using a NO microsensor. They show that, in normoxia, an in-crease in neural discharge is accompanied by a decrease in tissue NO generation and by a decrease in tissue O 2 following perfusion with L-NAME. Thus, their observation confirms that NO is produced endogenously, and that NO has an inhibitory effect on carotid chemoreceptor activity. Moreover, Iturriaga et al. [15] reported a transient decrease of the tissue NO level during the first minute of acute hypoxia in the perfused cat carotid body. This may not be fully compatible with the idea that there is disinhibition of the carotid afferent discharge in hypoxia, which may require a sustained reduction of the amount of NO during hypoxia in the carotid body.
To determine the effect of acute hypoxia on endogenous NO production in the carotid body, the present study aimed to measure directly the change of NO concentration induced by acute hypoxia in the superfused rat carotid body in vitro. It was found that the amount of NO increased significantly during acute hypoxia and that the hypoxia-induced elevation of NO was largely reversed by L-NAME. Our results support the idea that NO is an inhibitory modulator in the hypoxic response of the carotid chemoreceptor.
Materials and methods

Isolation of the carotid body
The experimental protocol for this study was approved by the Committee on the use of Live Animals in Teaching and Research of The University of Hong Kong. Following the induction of deep anesthesia with halothane, Sprague-Dawley rats (250-300 g) were decapitated and the carotid bifurcation was excised rapidly. The carotid body was carefully dissected free from the bifurcation in chilled rat Ringer's solution oxygenated with 95% O 2 and 5% CO 2 . The carotid body was then incubated in a tissue bath with collagenase (0.06%) and protease (0.02%) in oxygenated Ringer for 30 min at 35±1°C [16] .
Superfusion and in vitro electrophysiology
The carotid body was held in the recording chamber at 35±1°C, and superfused (2 ml/min) with oxygenated Ringer's solution. Acute hypoxia was induced by switching the perfusate to Ringer's solution gassed with 95% N 2 and 5% CO 2 . For the electrophysiological studies, recordings were made from the sinus nerve to measure for single fiber activity with a suction electrode. The signal was amplified, filtered, monitored, digitized, and stored for later analysis.
Oxygen electrode
The O 2 reduction in palladium-modified electrodes is described in detail elsewhere [9, 19] . In this study, palladium particles were electrodeposited on the surface of a Pt wire (0.127 mm diameter, 0.5 mm length) electrode, to form the O 2 sensor. To eliminate interference and avoid fouling (by proteins etc.) of the O 2 sensor, a thin permselective film of Nafion was further coated on the outer layer of the O 2 sensor. Using a CHI 660A electrochemical analyzer (CH Instruments, USA), all electrochemical experiments were carried out using a single-compartment cell. A Pt wire was used as the counter electrode, while a Ag/AgCl electrode was used as the reference electrode, and a Pt/Pd/Nafion-modified electrode as the working electrode. The electrodeposited Pd particles were formed on the Pt wire electrode in a freshly prepared modifier solution (2.0 mM K 2 PdCl 6 in 0.1 M HCl) by cycling the potential from +0.30 to -0.50 V at a scan rate of 50 mV/s. In the presence of the prepared Pd, the film displays on the electrochemical analyzer took the form of a well-behaved cyclic voltammogram with the characteristic peaks of the formation and reduction of the oxide layer. The amount of electrodeposited Pd was controlled by the number of cycles. The above-modified electrode was then immersed in 0.5% Nafion-alcohol solution for 9 s and dried in air. The point of using Nafion coating is to eliminate interference and avoid fouling of the electrode during detection. To calibrate the O 2 detector, Ringer's solution of various O 2 concentrations was passed through the working electrode. The current responses of the working electrode were determined. Although the Pt/Pd electrode has a good resolution, it is readily fouled by proteins and, thus, we used the Pt/Pd/Nafion electrode to measure the O 2 concentration in our experiments.
Nitric oxide electrode NO standards were prepared by the serial dilution of a saturated NO solution. Preparation of the saturated NO solution involved meticulously excluding O 2 , as NO is destroyed by O 2 . To produce the saturated NO solution, pH-7.0 phosphate-buffered saline (PBS) was bubbled with pure N 2 for 30 min to remove O 2 . Then the solution was bubbled with NO gas (Matheson) for 30 min and kept under NO atmosphere until use. Standards were made fresh for each experiment and kept in a glass flask with a rubber septum. Electrochemical experiments were performed using a CHI 660A Electrochemical Analyzer (CH Instruments, USA) at room temperature and a three-compartment cell with a Ag/AgCl reference electrode, a Pt wire auxiliary electrode and a chemically modified electrode as the working electrode.
To prepare a NO electrode, a laboratory-made Pt wire working electrode (0.127 diameter with 0.5 mm long) insulated with polyethylene tubing was dipped in 0.5% Nafion in alcohol for 6 s and dried in air. The Nafion-coated modified electrode was further modified with palladium and iridium oxide particles, as reported elsewhere [35] . The sensitivity of the NO electrode can be improved by electrocatalytic oxidation of NO by palladium and iridium oxide particles [35] . To improve the selectivity of this NO electrode, a thin film of poly-o-aminophenol (POAP) was deposited [36] on the outer layer by cycling the potential in the solution of 1 mM OAP monomer. The POAP film formed under this condition is permselective and very useful in both preventing the electroactive species from reaching the electrocatalytic centers and keeping the NO electrode from fouling [36] . The NO sensor was calibrated by successively injecting various concentrations of NO into the Ringer's solution in the recording chamber as shown in Fig. 1 . The inset of Fig. 1 indicates that the current response to various NO concentrations in the nanomolar range is very close to linear. The detection limit of our NO electrode is about 10 nM with a signal-to-noise ratio of 3. The linear equation in the inset is specified by y=a+bx, where a=0.1421, b=0.0538 and the coefficient r is found to be 0.9983. There were no differences in the current response to NO in Ringer's solution gassed with 95% O 2 /5% CO 2 or 95% N 2 /5% CO 2 in the presence or absence of dopamine (30 nM). Also, dopamine (30 nM) itself did not cause any current response of the electrode (data not shown). The current response of the NO electrode was examined before and after the experiment. The NO electrode could be used in experiments for 1-2 weeks without changes in performance.
Experimental paradigm
The electrode and carotid body were equilibrated in the perfusate for 15-30 min. The NO electrode was carefully placed on the surface of the carotid body under visual guidance with a dissecting microscope. The distance between the tip and the carotid body was about 50 µm. Following current recording in the resting situa-tion for 10-15 min, hypoxia was induced for 10 min following by recovery for 20-30 min. For the drug studies, L-NAME (500 µM) or L-arginine (1 mM) was added freshly to the oxygenated Ringer's and perfused for 10 min before hypoxia. For the electrophysiological study, hypoxia was induced for 4 min followed by recovery for 20-30 min.
Materials and pharmacological agents
The rat Ringer's solution contained (mM): NaC1 125, KC1 3.1, NaHCO 3 
Results
The NO sensor was placed approximately 50 µm from the surface of the carotid body to measure the release of NO. In acute hypoxia, there was a consistent increase of the NO level (Fig. 2) . The NO level rose within 1 min of hypoxia when the O 2 concentration in the bath was reduced by a half. The amount of NO release increased progressively with the fall of O 2 concentration and it reached a plateau following 4 min of hypoxia, when the O 2 concentration had decreased to its nadir (about 1 mmHg). On average the maximal level of NO release was 17±2 nM (n=8). During recovery from hypoxia, the amount of NO release decreased gradually back to the resting level (Fig. 2) . To determine whether hypoxia itself affects the NO measurement, we performed a control experiment, in which the same hypoxic trial was run at the end of each experiment after the carotid body had been removed: the current recording did not change during hypoxia. Hence, the amount of NO release appears to depend on the O 2 supply to the carotid body.
To test whether the source of NO release is specific to the carotid body, we determined hypoxia-induced NO release in the presence of different numbers of carotid bodies. In this case, carotid bodies were aggregated close to the NO electrode and the electrode was placed in the middle of the spacing between the carotid bodies. Figure 3 shows that the amount of NO release during hypoxia depends on the number of carotid bodies used for the measurement. This suggests that the amount of NO release is determined by the amount of active substrates in the carotid body for the generation of NO.
The elevation of NO release during hypoxia may be caused by increased NO production in the carotid body. To test this hypothesis, the carotid body was perfused with L-arginine (1 mM) for 10 min before acute hypoxia. In resting conditions, L-arginine increased NO release by 78±21 nM (n=4) and it also increased the release of NO during hypoxia by 91±22 nM (n=4) (Fig. 4) .
Moreover, the carotid body was perfused with a competitive NOS inhibitor L-NAME (500 µM) for 10 min In time intervals A and C, the solution was saturated with 95% O 2 and 5% CO 2 , while in interval B, the solution was saturated with 95% N 2 and 5% CO 2 . The current was measured at a voltage of -0.40 V before acute hypoxia. Perfusion of L-NAME did not cause any detectable changes in the basal level of NO. In contrast, L-NAME attenuated hypoxia-induced NO release (Fig. 4) . On average, L-NAME blocked the hypoxic response by about 70% (n=8) (Fig. 4) . Following washout for 30 min, the hypoxic response was partially recovered. Results suggest that the NOS-mediated production of NO in the carotid body increases in acute hypoxia and that this is responsible for the hypoxia-induced elevation of NO release. In addition, the lack of change of the basal NO level during L-NAME perfusion suggests that basal NO release is below the NO electrode's resolution, which is about 10 nM. To verify this argument, L-NAME was perfused for 10 min when the NO electrode was surrounded by four carotid bodies. In this setting, we observed a small but consistent decrease of the NO level by about 12±2 nM (n=4). This supports the idea that the carotid body produces and releases a small basal amount of NO in resting conditions.
To confirm the inhibitory role of NO in carotid chemoreceptor activity in hypoxia, we determined the effects of L-NAME on the afferent discharge of the carotid body. Perfusion of L-NAME did not change the resting discharge rate in three of five carotid bodies (Fig. 5) but the resting discharge was increased in the remaining two carotid bodies. On average, the basal discharge increased slightly (125.0±17.6%, n=5, P=0.35, Wilcoxon sign ranked test) with L-NAME perfusion. In contrast, L-NAME enhanced the hypoxic response of the carotid afferent discharge in all carotid bodies by 2.5-fold on average (251.7±27.2%, n=5, P=0.04, Wilcoxon sign ranked test) (Fig. 5) . During hypoxia, the discharge rate rose rapidly in the first 2 min and reached its peak by 3 min of hypoxia. This is consistent with the hypothesis that NO inhibits chemoreceptor activity during hypoxia in the carotid body.
Discussion
The major observations of this study are that the NO level in the rat carotid body increases in acute hypoxia and that the hypoxia-induced NO elevation is abolished by pretreating with L-NAME. These results suggest that there is an increase of endogenous NO production during acute hypoxia in the rat carotid body. The increase of NO, in turn, inhibits the carotid chemoreceptor activity in response to hypoxia and thus L-NAME enhances the 906 Fig. 3 The peak NO release during hypoxia measured in the presence of different numbers of carotid bodies surrounding the NO sensor. Each group represents 8 observations (n=8). Note the peak NO release increased significantly in the presence of 2 or 3 carotid bodies. Yet, the peak NO release did not further increase with 4-8 carotid bodies, probably because of the increased distance between the NO sensor and the carotid bodies. * P<0.05 (one-way ANOVA) significant difference compared to group 1 data Note that pretreatment with L-NAME (500 µM, 10 min) attenuated NO release in hypoxia. On average, the NO release was reduced significantly by 70% of control (n=8) hypoxic response of the carotid afferent discharge. The elevation of NO generation during hypoxia suggests that NO plays an inhibitory role in the hypoxic chemotransduction in the carotid body.
Technical considerations
The amount of NO release was found to be much less than that reported recently in a study of the perfused cat carotid body [6] . This may be mainly because we measured NO at the surface of the carotid body rather than inside the organ, as reported previously. In this regard, we are fully aware that the NO measurement in the present study is only an estimation of NO generation, and that the estimate is below the tissue NO level. The tip size of our NO sensor (127 µm) and the small size of the rat carotid body (about 300 µm in diameter) made it difficult to measure tissue NO levels in our studies. Also, the rat carotid body is much smaller than that in the cat, and such a difference may account for the low NO level recorded in the present study. Note that the amount of NO detected was found to depend on the number of carotid bodies surrounding the NO electrode.
Although the NO electrode did not respond to a low concentration (nM) of dopamine, it did respond to high concentrations (1 µM); however, the current response was more selective for NO than dopamine, with a ratio of about 1:100. Thus, the NO electrode may detect dopamine in the micromolar concentration range and this may explain why L-NAME did not completely block the release of NO in hypoxia. Furthermore, the rate of NO removal by O 2 may be less in hypoxia than in resting conditions, and this may account for some of the differences in NO levels during hypoxia. Although this possibility cannot be excluded in this study, it may not be the main cause of NO elevation in hypoxia, because there were no differences in the current responses to NO in either oxygenated or deoxygenated Ringer's when the NO electrodes were calibrated in the perfusing chamber. Also, cyanide (2 mM) elevated NO levels in the absence of changes in O 2 tension in the perfusate (data not shown).
Sources of NO
We believed that there is a constitutive generation of NO in resting conditions, although the amount of NO generated in resting conditions is lower than that in hypoxia. Thus, at rest, blocking NOS with L-NAME caused a detectable decrease of NO levels only in the measurements with four carotid bodies surrounding the NO electrode. Also, L-NAME perfusion did not consistently increase the basal discharge and the increase of discharge rate was much less than that in hypoxia. The electrophysiological findings are consistent with previous reports of the cat carotid body in vivo [27] and in vitro [30] , suggesting that the amount of NO is relatively low in resting conditions compared with that in hypoxia.
Neuronal NOS (nNOS) is prominent in nerve fibers in the carotid body [23, 29] . Wang et al. [31] observed that NOS is also expressed in the plexus of nerve fibers in the lobules of parency wall cells and near small blood vessels of the carotid body in cats (see [32] for review). In addition to the nNOS in the nerve fibers, Gozel et al. [10] have shown that endothelial NOS (ecNOS) is expressed in the rat carotid body. Hence, nNOS in nerve fibers and/or ecNOS in the endothelium could be responsible for the increase of NO production in response to hyp-907 Fig. 5 A Single-fiber recording of the carotid afferent activity during resting conditions and hypoxia with or without the pretreatment with L-NAME (500 µM, 10 min). The partial pressure of O 2 (PO 2 ) is shown in the lower trace. The discharge rate (Hz) increased with hypoxia (10 min) and it was elevated by L-NAME. Note that the resting activity did not change with the perfusion of L-NAME in this carotid body. B On average L-NAME significantly increased the discharge rate in hypoxia by 2.5-fold (n=5) oxia. However, the differential role, if any, of isoforms of NOS in the rat carotid body could not be addressed in the present study because L-NAME is not specific to any one of the NOS isoforms.
The increase of NO production in hypoxia
The activation of NOS in the nerve fibers or in the endothelium is driven by calcium-dependent mechanisms (see [28] for review). An elevation of the cytosolic calcium concentration to about 400 nM is required for binding between calmodulin and NOS to occur, and this is necessary for the enzyme to become fully active. During hypoxia, afferent discharge increases and may be associated with the increased cytosolic calcium concentration in the nerve fibers apposed to the chemoreceptors. In addition, hypoxia is a physiological stimulus for elevating the cytosolic calcium level in endothelial cells [1, 21] . Hence, the increased cytosolic calcium level may be responsible for the increase of NO production in the nerve fibers and endothelium during hypoxia.
Moreover, it is well known that a wide spectrum of agents stimulate NO production via receptor-mediated mechanisms in endothelial cells. For example, hypoxia stimulates the secretion and synthesis of endothelin [2, 5, 12, 20] . Endothelin can stimulate NO synthesis via endothelin receptors in endothelial cells and causes vasodilatation. Hence, it is plausible that endothelial receptors for these agents mediate the increase of NO generation during hypoxia in the carotid body.
With all the isoforms of NOS, L-arginine, NADPH and O 2 are co-substrates for synthesizing NO. It is generally accepted that concentrations of L-arginine and NADPH are high in the tissues and are unlikely to be a limiting factor. Although the low level of O 2 during hypoxia may reduce NO synthesis in the catalytic pathway [23, 34] , it may not be the dominant factor because the residual amount of O 2 in tissues during hypoxia may minimize the reduction of NO synthesis. Interestingly, it has been shown that the NO concentration in brain tissue increases during cerebral ischemia [33] , suggesting that O 2 is taken from the tissue for the conversion of L-arginine to N ω -hydroxyarginine. Hence, the O 2 concentration may not be the only factor that determines the amount of NO produced in the carotid body during hypoxia.
Physiological significance
Our results are consistent with the idea that NO inhibits carotid chemoreceptor activity during hypoxia. Summers et al. [26] has demonstrated that NO inhibits L-type voltage-gated calcium channels in glomus cells by a direct action on the channel protein. Hence, NO may attenuate the calcium influx and, thus, decrease the excitability of, and neurotransmitter release from, the glomus cells during hypoxia.
In addition, the increase of NO during hypoxia may decrease the metabolic rate and O 2 consumption of the carotid body. It is well established that NO binds with the heme-O 2 site of cytochrome C oxidase and affects mitochondrial respiration [4, 24] . NO inhibits O 2 consumption in skeletal muscles of conscious dogs [25] . Following the blockade of NOS, the O 2 consumption rate increased in cultured endothelial cells [8] . Moreover, Boveris et al. [3] reported that the metabolic inhibition is inversely related to the O 2 -to-NO ratio. Hence, our results suggest a decrease of the O 2 -to-NO ratio and an increased inhibition of O 2 consumption in the carotid body during hypoxia.
The elevation of NO during hypoxia may also enhance blood flow in the carotid body due to the NOinduced vasodilatation. Buerk and Lahiri [6] observed that the blockade of NOS reduces the tissue O 2 level and increases O 2 consumption in the perfused cat carotid body. They suggest that the constitutive release of NO plays a major role in the control of O 2 supply by causing the vasodilatation. In our study the tissue O 2 level depends on the perfusate and there are no blood flow changes due to the vasodilatation. Hence, the reduction of carotid afferent activity may reflect the effects of NO on the metabolic rate and/or the cytosolic calcium level of the chemoreceptors. Nonetheless, the profile of NO levels during hypoxia may be different due to the vascular effect of NO because, in the perfused cat carotid body, there is a transient decrease of the tissue NO level during hypoxia [15] .
